Eli Lilly's quarter was messy. What to do with the stock is more clear-cut 0 30.10.2024 21:42 CNBC We're upgrading our rating on the drugmaker to a buy-equivalent 1. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
